Skip to main content
. 2019 May;112(5):600–648. doi: 10.5935/abc.20190075

Table 7.3.

In utero management of tachycardias

Diagnosis In utero management GOR/LOE Comments
Intermittent tachycardia
SVT or AF Observation I/B Frequent fetal HR auscultation
VT ≥ 200 bpm Antiarrhythmic medication IIa/C  
Sustained tachycardia
SVT or AF with hydrops or ventricular dysfunction First or second line (transplacental) drugs:   See Table 7.4, for dosing ranges and monitoring recommendations
  Digoxin I/B  
  Sotalol I/B  
  Combination of drugs (transplacental) IIb/B Combination treatments are used for severe, drug-refractory cases. Consider preterm delivery if near term
  Third line (transplacental):    
  Amiodarone I/B  
  Contraindicated: verapamil III/A  
  Contraindicated: procainamide III/B  
  Direct fetal treatment:    
  IM digoxin IIa/B  
  Intracordal digoxin IIb/B  
  Contraindicated: Intracordal adenosine III/B  
SVT ≥ 200 bpm, without hydrops or ventricular dysfunction (usually SVT has HR ≥ 220 bpm; consider other causes if HR < 220 bpm). First or second line:    
Digoxin I/B See Table 7.4, for doses and monitoring recommendations
Sotalol I/B Frequent monitoring of fetal well-being and maternal/fetal drug toxicity. Consider preterm delivery if near term.
  Third line:    
  Amiodarone IIb/B  
  Contraindicated: verapamil IIb/A  
  Contraindicated: procainamide III/B  
  Observation I/B  
SVT < 200 bpm, without hydrops or ventricular dysfunction Sotalol I/B Digoxin increases AVB and decreases ventricular response. Consider preterm delivery if near term
AF Digoxin I/B
  Amiodarone IIb/B  
  Contraindicated: procainamide III/B  
VT ± hydrops   I/C  
First line treatment Magnesium IV Lidocaine IV Propranolol (oral) I/C FMCG (if available) to measure QTc interval.
Start with magnesium IV, then lidocaine, load + maintenance.
Note: maternal intravenous magnesium should not be used for > 48 h.
Consider preterm delivery if near term.
Second line treatment Mexiletina (oral) Sotalol I/C  

AF: atrial flutter; GOR: grade of recommendation; IV: intravenous; HR: heart rate; IM: intramuscular; FMCG: fetal magnetocardiography; LOE: level of evidence; SVT: supraventricular tachycardia; VT: ventricular tachycardia.

Source: adapted from Donofrio MT et al.17